Kidney Cancer

Study Finds Radiation Remodels T-Cell Responses in Patients with RCC
October 22, 2020

Researchers demonstrated for the first time that radiation remodels T-cell responses found within the tumors of patients with renal cell carcinoma.

BIONIKK Trial Sees Improved Responses with Molecularly-Guided Therapy in Patients with mRCC
September 23, 2020

Findings from the noncomparative, phase 2, biomarker-driven BIONIKK trial support the use of molecularly-directed frontline therapy as means to enrich responses in patients with metastatic clear cell renal cell carcinoma.

4-Year Results from Phase 3 CheckMate-214 Trial Continue to Show Long-Term Benefit in RCC
September 18, 2020

With a follow-up of 4 years, nivolumab plus ipilimumab continued to demonstrate superior, long-term overall survival and durable responses compared to sunitinib in patients with advanced renal cell carcinoma.